UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Double Negative (CD3+4−8−) TCRαβ Splenic Cells from Young NOD Mice Provide Long-Lasting Protection against Type 1 Diabetes

PloS one, 2010-07, Vol.5 (7), p.e11427

2010

Volltextzugriff (PDF)

Insights into the pathogenesis of type 1 diabetes: a hint for novel immunospecific therapies

Current molecular medicine, 2001-07, Vol.1 (3), p.357-378

2001

Volltextzugriff (PDF)

Double Negative (CD3+4−8−) TCRαβ Splenic Cells from Young NOD Mice Provide Long-Lasting Protection against Type 1 Diabetes

PloS one, 2010-07, Vol.5 (7), p.e11427

2010

Volltextzugriff (PDF)

Constantin A. Bona, M.D., Ph.D

International reviews of immunology, 2016, Vol.35 (1), p.1-3

2016

Volltextzugriff (PDF)

Humanized HLA-DR4.RagKO.IL2R[gamma]cKO.NOD mice sustain the complex vertebrate life cycle of Plasmodium falciparum malaria

Malaria journal, 2014-09, Vol.13 (1), p.386-386

2014

Volltextzugriff (PDF)

Humanized HLA-DR4 Mice Fed with the Protozoan Pathogen of Oysters Perkinsus Marinus

PloS one, 2014-01, Vol.9 (1), p.e87435

2014

Volltextzugriff (PDF)

Double Negative TCR[alpha][beta] Splenic Cells from Young NOD Mice Provide Long-Lasting Protection against Type 1 Diabetes

PloS one, 2010-07, Vol.5 (7), p.e11427

2010

Volltextzugriff (PDF)

Double Negative

PloS one, 2010-07, Vol.5 (7), p.e11427

2010

Volltextzugriff (PDF)

CD28 Signaling in T Regulatory Precursors Requires p56lck and Rafts Integrity to Stabilize the Foxp3 Message

The Journal of immunology (1950), 2009-01, Vol.182 (1), p.102-110

2009

Volltextzugriff (PDF)

Nonobese Diabetic (NOD) Mice Lack a Protective B-Cell Response against the “Nonlethal” Plasmodium yoelii 17XNL Malaria Protozoan

Malaria research and treatment, 2016, Vol.2016, p.6132734-9

2016

Volltextzugriff (PDF)

A Peptide-Major Histocompatibility Complex II Chimera Favors Survival of Pancreatic β-Ιslets Grafted in Type 1 Diabetic Mice

Transplantation, 2008-06, Vol.85 (12), p.1717-1725

2008

Volltextzugriff (PDF)

Abstract #322: A Novel Approach for Detection/Immunoregulation in Type 1 Diabetes

Endocrine practice, 2006-03, Vol.12, p.24

2006

Volltextzugriff (PDF)

RNA degradation precedes DNA cleavage in autoreactive CD4 T cells suppressed by calicheamicin gamma1

International immunopharmacology, 2004-04, Vol.4 (4), p.521

2004

Volltextzugriff (PDF)

Double Negative (CD3+4-8-) TCRab Splenic Cells from Young NOD Mice Provide Long-Lasting Protection against Type 1 Diabetes

PloS one, 2010-07, Vol.5 (7)

2010

Volltextzugriff (PDF)

RNA degradation precedes DNA cleavage in autoreactive CD4 T cells suppressed by calicheamicin γ1

International immunopharmacology, 2004-04, Vol.4 (4), p.521-526

2004

Volltextzugriff (PDF)

A Model for Antigen-Specific T-Cell Anergy: Displacement of CD4-p56 lck Signalosome from the Lipid Rafts by a Soluble, Dimeric Peptide-MHC Class II Chimera

The Journal of immunology (1950), 2003-06, Vol.170 (12), p.5981-5992

2003

Volltextzugriff (PDF)

Thymic Development of CD4 super(+25) super(h)i Foxp3 super(+ T-Regulatory Cells Echoes their Suppressogenic Capacity in Periphery)

The Open autoimmunity journal, 2009-01, Vol.1, p.64-78

2009

Volltextzugriff (PDF)

Thymic Development of CD4+25hi Foxp3+ T-Regulatory Cells Echoes their Suppressogenic Capacity in Periphery

The Open autoimmunity journal, 2009-07, Vol.1 (1), p.64-78

2009

Volltextzugriff (PDF)

Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II-peptide chimera

Nature biotechnology, 2001-02, Vol.19 (2), p.142-147

2001

Volltextzugriff (PDF)

Disruption of the IL‐1β gene diminishes acetylcholine receptor‐induced immune responses in a murine model of myasthenia gravis

European journal of immunology, 2001-01, Vol.31 (1), p.225-232

2001

Volltextzugriff (PDF)

Down-regulation of diabetogenic CD4 super(+) T cells by a soluble dimeric peptide-MHC class II chimera

Nature immunology, 2002-04, Vol.3 (4), p.383-391

2002

Volltextzugriff (PDF)

Modulation of CD4 T cell function by soluble MHC II-peptide chimeras

International reviews of immunology, 2001, Vol.20 (5), p.547-573

2001

Volltextzugriff (PDF)

T-cell Tolerance and Autoimmune Diabetes

International reviews of immunology, 2001, Vol.20 (2), p.301-331

2001

Volltextzugriff (PDF)

Long-term silencing of autoimmune diabetes and improved life expectancy by a soluble pHLA-DR4 chimera in a newly-humanized NOD/DR4/B7 mouse

Human Vaccines & Immunotherapeutics, 2014, Vol.10 (3), p.693-699

2014

Volltextzugriff (PDF)

A Model for Antigen-Specific T-Cell Anergy: Displacement of CD4-p56lck Signalosome from the Lipid Rafts by a Soluble, Dimeric Peptide-MHC Class II Chimera

The Journal of immunology (1950), 2003-06, Vol.170 (12), p.5981

2003

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(35)
Berichte
(1)

Sprache

Englisch
(36)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Animals
(6)
Mice
(6)
Humans
(4)
Analysis
(3)
Antigens
(3)
Diabetes Mellitus, Type 1 - Immunology
(3)
Health Aspects
(3)
Immunotherapy
(3)
Lymphocytes
(3)
Recombinant Fusion Proteins - Immunology
(3)
T Cells
(3)
Antibodies
(2)
Antineoplastic Agents
(2)
Autoimmune Diseases
(2)
Autoimmunity
(2)
B Cells
(2)
Biological And Medical Sciences
(2)
Cd4 T Cells
(2)
Cd4-Positive T-Lymphocytes - Drug Effects
(2)
Cd4-Positive T-Lymphocytes - Immunology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Double Negative (CD3+4−8−) TCRαβ Splenic Cells from Young NOD Mice Provide Long-Lasting Protection against Type 1 Diabetes

Insights into the pathogenesis of type 1 diabetes: a hint for novel immunospecific therapies

Double Negative (CD3+4−8−) TCRαβ Splenic Cells from Young NOD Mice Provide Long-Lasting Protection against Type 1 Diabetes

Constantin A. Bona, M.D., Ph.D

Humanized HLA-DR4.RagKO.IL2R[gamma]cKO.NOD mice sustain the complex vertebrate life cycle of Plasmodium falciparum malaria

Humanized HLA-DR4 Mice Fed with the Protozoan Pathogen of Oysters Perkinsus Marinus

Double Negative TCR[alpha][beta] Splenic Cells from Young NOD Mice Provide Long-Lasting Protection against Type 1 Diabetes

Double Negative

CD28 Signaling in T Regulatory Precursors Requires p56lck and Rafts Integrity to Stabilize the Foxp3 Message

Nonobese Diabetic (NOD) Mice Lack a Protective B-Cell Response against the “Nonlethal” Plasmodium yoelii 17XNL Malaria Protozoan

A Peptide-Major Histocompatibility Complex II Chimera Favors Survival of Pancreatic β-Ιslets Grafted in Type 1 Diabetic Mice

Abstract #322: A Novel Approach for Detection/Immunoregulation in Type 1 Diabetes

RNA degradation precedes DNA cleavage in autoreactive CD4 T cells suppressed by calicheamicin gamma1

Double Negative (CD3+4-8-) TCRab Splenic Cells from Young NOD Mice Provide Long-Lasting Protection against Type 1 Diabetes

RNA degradation precedes DNA cleavage in autoreactive CD4 T cells suppressed by calicheamicin γ1

A Model for Antigen-Specific T-Cell Anergy: Displacement of CD4-p56 lck Signalosome from the Lipid Rafts by a Soluble, Dimeric Peptide-MHC Class II Chimera

Thymic Development of CD4 super(+25) super(h)i Foxp3 super(+ T-Regulatory Cells Echoes their Suppressogenic Capacity in Periphery)

Thymic Development of CD4+25hi Foxp3+ T-Regulatory Cells Echoes their Suppressogenic Capacity in Periphery

Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II-peptide chimera

Disruption of the IL‐1β gene diminishes acetylcholine receptor‐induced immune responses in a murine model of myasthenia gravis

Down-regulation of diabetogenic CD4 super(+) T cells by a soluble dimeric peptide-MHC class II chimera

Modulation of CD4 T cell function by soluble MHC II-peptide chimeras

T-cell Tolerance and Autoimmune Diabetes

Long-term silencing of autoimmune diabetes and improved life expectancy by a soluble pHLA-DR4 chimera in a newly-humanized NOD/DR4/B7 mouse

A Model for Antigen-Specific T-Cell Anergy: Displacement of CD4-p56lck Signalosome from the Lipid Rafts by a Soluble, Dimeric Peptide-MHC Class II Chimera

Aktive Filter

Suchergebnisse filtern